These inks can be utilized in a variety of printing technologies, including inkjet printing .The novel conductive inks were invented by Professor Shlomo Magdassi, Dr. Alexander Kamyshny and Michael Grouchko from the Institute of Chemistry at the Hebrew University.
Method enables accurate identification of a suspect's DNA in crime scenes even when DNA evidence comprises a mixture from multiple individuals
The lessons are conducted in small groups via the online study site of the company, eTeacher, which recently signed an agreement of cooperation with Yissum, the technology transfer company of the Hebrew University.
Yissum introduces solid organic electric battery based upon treated potatoes. This simple, sustainable, robust device can potentially provide an immediate inexpensive solution to electricity needs in parts of the world lacking electrical infrastructure.
Yissum introduces Dralgo, a novel computational platform for accelerated discovery of promising drug candidates. The new technology will be presented by Professor Amiram Goldblum from the Hebrew University on Tuesday, June 15 at the Technology Transfer Session II of the ILSI Biomed Israel 2010 conference, to be held at the David Intercontinental Hotel, Tel Aviv, Israel.
The technology, invented by Dr. Raanan Fattal from the Hebrew University's School of Computer Science and Engineering, is called Edge Avoiding Wavelets and it enables better and faster detail enhancement and preserves edges when sharpening digital images.
Yissum has also announced that, together with the Technion Research and Development Foundation (TRDF), the technology transfer arm of the Technion Israel Institute of Technology, it will exclusively license to Avraham the commercial rights of Ladostigil, a novel cholinesterase, brain-selective monoamine oxidase inhibitor and neuroprotective agent for treatment of Alzheimer's disease and other neurodegenerative diseases.
The novel system monitors people's movements and use of open space to provide accurate data for use in healthcare, urban planning, retail yield management, law enforcement and tourism management. The technology was developed by Dr. Noam Shoval and Michal Isaacson, of the Hebrew University’s Department of Geography.
The first collaboration is for the development and commercialization of a novel methodology for producing slow and controlled release of herbicides. The innovative technique will minimize herbicide contamination of soil and water. It was invented by Prof. Shlomo Nir and Dr. Yael Mishael from the Department of Soil and Water Sciences, and by Prof. Baruch Rubin, from the Robert H. Institute of Plant Science and Genetics in Agriculture, all from the Hebrew University’s Robert H. Smith Faculty of Agriculture, Food and Environment.
Yissum presents EtoCleanTM, a new antiviral hand sanitizer which has been found to be highly effective against the swine flu virus. The novel product was invented by Professor Elka Touitou from the School of Pharmacy, at the Hebrew University of Jerusalem and is being developed by Novel Therapeutic Technologies (NTT), a spin-off company of Yissum.
This novel method for content analysis, invented by Professor Ari Rappoport and Mr. Oren Tsur from the Hebrew University School of Computer Science and Engineering, is specifically designed to automatically rank book and product reviews according to their estimated helpfulness.
The invention, developed by HUJI Professors Doron Steinberg and Morris Srebnik, together with Professor Itzhack Polacheck from the Hadassah Medical Organization, utilizes novel heterocyclic compounds that disrupt cell-cell communication, thereby interfering with the formation of biofilms.
Under the agreement, BrightSource will fund research in the laboratories of Professors Daniel Mandler, and Shlomo Magdassi, both from the Institute of Chemistry at the Hebrew University of Jerusalem.
According to the terms of the agreement, Roche has selected six promising research projects in the fields of stem cells, biomarkers, and novel molecules for the treatment of metabolic diseases, initiated by Hebrew University researchers.
The novel device will have 400 times higher gain than THz quantum cascade lasers, the only coherent T-ray sources existing today. This invention will make T-ray based cameras and spectrometers practical, ushering a new era in security and medical imaging.
Yissum announced that it has licensed a novel package of stem cell related technologies to TheraCell, Inc., which will further develop and commercialize the technology for advanced regenerative medicine procedures such as spinal fusion. The technology was invented by a team headed by Professor Dan Gazit from the Faculty of Dental Medicine.
The collaboration is funded by the Israel-U.S. binational BIRD Foundation
The technology was developed by Prof. Simon Benita at the Hebrew University's School of Pharmacy.
Professor Itai Bab and Professor Raphael Mechoulam, from the School of Pharmacy at the Hebrew University of Jerusalem, invented a new drug candidate for the treatment of osteoporosis that both inhibits bone resorption and stimulates bone formation.
Z-Cube has received the worldwide exclusive right to develop and commercialize the technology for pain applications and will sponsor a research program to be conducted by Professor Elka Touitou from the Hebrew University's Faculty of Medicine.